Perrigo (PRGO) Accumulated Expenses (2013 - 2026)
Perrigo (PRGO) posted quarterly Accumulated Expenses of $153.5 million for Q1 2026, down 39.52% year-over-year from $253.8 million in Q1 2025, and up 36.81% quarter-over-quarter from $112.2 million in Q4 2025.
Perrigo (PRGO) Accumulated Expenses (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Accumulated Expenses for 14 consecutive years, with $153.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 39.52% year-over-year to $153.5 million; the TTM figure through Mar 2026 stood at $153.5 million (down 39.52% YoY), while the FY2025 annual figure was $112.2 million, down 8.93% from the prior year.
- Accumulated Expenses climbed to $153.5 million in Q1 2026 per PRGO's latest filing, from $112.2 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $363.1 million in Q3 2025 and bottomed at $88.6 million in Q2 2022.
- Historically, Accumulated Expenses has averaged $177.2 million across 5 years, with a median of $127.0 million in 2023.
- Annual changes were most pronounced in 2022 — Accumulated Expenses tumbled 55.8% — and 2024, when it soared 237.09%.
- Perrigo's Accumulated Expenses stood at $136.4 million in 2022, then dropped by 6.89% to $127.0 million in 2023, then decreased by 2.99% to $123.2 million in 2024, then fell by 8.93% to $112.2 million in 2025, then soared by 36.81% to $153.5 million in 2026.
- Business Quant data shows PRGO's Accumulated Expenses at $153.5 million in Q1 2026, $112.2 million in Q4 2025, and $363.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 153.20 Mn |
| Mar 28, 2026 | 153.50 Mn |
| Dec 31, 2025 | 112.20 Mn |
| Sep 27, 2025 | 363.10 Mn |
| Jun 28, 2025 | 122.40 Mn |
| Mar 29, 2025 | 253.80 Mn |
| Dec 31, 2024 | 123.20 Mn |
| Sep 28, 2024 | 227.00 Mn |
| Jun 29, 2024 | 125.40 Mn |
| Mar 30, 2024 | 359.00 Mn |
| Dec 31, 2023 | 127.00 Mn |
| Sep 30, 2023 | 262.30 Mn |
| Jul 1, 2023 | 104.40 Mn |
| Apr 1, 2023 | 106.50 Mn |
| Dec 31, 2022 | 136.40 Mn |
| Oct 1, 2022 | 242.70 Mn |
| Jul 2, 2022 | 104.10 Mn |
| Apr 2, 2022 | 88.60 Mn |
| Dec 31, 2021 | 118.50 Mn |
| Oct 2, 2021 | 339.90 Mn |